Literature DB >> 7621853

The acetylation phenotype: does it contribute to the non-linearity of the metabolite pharmacokinetics of metamizol?

N Bacracheva, V Vlahov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7621853     DOI： 10.1007/bf00202178

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  Simultaneous determination of the main metabolites of dipyrone by high-pressure liquid chromatography.

Authors:  D Damm
Journal:  Arzneimittelforschung       Date:  1989-11

2.  Formation and excretion of dipyrone metabolites in man.

Authors:  E Zylber-Katz; L Granit; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone).

Authors:  M Volz; H M Kellner
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

4.  Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium.

Authors:  V Vlahov; M Badian; M Verho; N Bacracheva
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.

Authors:  A R Boobis; M J Brodie; G C Kahn; E L Toverud; I A Blair; S Murray; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

6.  Plasma kinetics of dipyrone metabolites in rapid and slow acetylators.

Authors:  M Levy; D Flusser; E Zylber-Katz; L Granit
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.